7-105981016-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152750.5(CDHR3):āc.298A>Gā(p.Ile100Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000465 in 1,611,542 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152750.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDHR3 | NM_152750.5 | c.298A>G | p.Ile100Val | missense_variant | 3/19 | ENST00000317716.14 | NP_689963.2 | |
CDHR3 | NM_001301161.2 | c.34A>G | p.Ile12Val | missense_variant | 2/18 | NP_001288090.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDHR3 | ENST00000317716.14 | c.298A>G | p.Ile100Val | missense_variant | 3/19 | 1 | NM_152750.5 | ENSP00000325954.9 |
Frequencies
GnomAD3 genomes AF: 0.000223 AC: 34AN: 152236Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000818 AC: 20AN: 244594Hom.: 0 AF XY: 0.0000831 AC XY: 11AN XY: 132434
GnomAD4 exome AF: 0.0000281 AC: 41AN: 1459188Hom.: 0 Cov.: 30 AF XY: 0.0000207 AC XY: 15AN XY: 725486
GnomAD4 genome AF: 0.000223 AC: 34AN: 152354Hom.: 0 Cov.: 30 AF XY: 0.000174 AC XY: 13AN XY: 74504
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 09, 2024 | The c.298A>G (p.I100V) alteration is located in exon 3 (coding exon 3) of the CDHR3 gene. This alteration results from a A to G substitution at nucleotide position 298, causing the isoleucine (I) at amino acid position 100 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at